Suzuken (9987) Stock Overview
Primarily engages in the distribution of pharmaceuticals in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
9987 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Suzuken Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥5,727.00 |
| 52 Week High | JP¥6,160.00 |
| 52 Week Low | JP¥4,406.00 |
| Beta | 0.099 |
| 1 Month Change | -0.90% |
| 3 Month Change | 1.29% |
| 1 Year Change | 12.78% |
| 3 Year Change | 53.54% |
| 5 Year Change | 47.03% |
| Change since IPO | 51.28% |
Recent News & Updates
Suzuken Co., Ltd. (TSE:9987) Shares Could Be 23% Above Their Intrinsic Value Estimate
Oct 28
Suzuken (TSE:9987) Will Pay A Dividend Of ¥50.00
Sep 28Suzuken (TSE:9987) Has Affirmed Its Dividend Of ¥50.00
Sep 11Recent updates
Suzuken Co., Ltd. (TSE:9987) Shares Could Be 23% Above Their Intrinsic Value Estimate
Oct 28Suzuken (TSE:9987) Will Pay A Dividend Of ¥50.00
Sep 28Suzuken (TSE:9987) Has Affirmed Its Dividend Of ¥50.00
Sep 11Suzuken (TSE:9987) Is Due To Pay A Dividend Of ¥50.00
Aug 25Suzuken (TSE:9987) Has Affirmed Its Dividend Of ¥50.00
Aug 11Suzuken (TSE:9987) Is Paying Out A Dividend Of ¥50.00
Jul 28Suzuken (TSE:9987) Will Pay A Dividend Of ¥50.00
Jul 14Suzuken's (TSE:9987) Profits May Be Overstating Its True Earnings Potential
May 22Suzuken Co., Ltd. (TSE:9987) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
May 16Suzuken Co., Ltd.'s (TSE:9987) Share Price Could Signal Some Risk
May 13Here's Why We Think Suzuken (TSE:9987) Is Well Worth Watching
Mar 31Suzuken Co., Ltd. (TSE:9987) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
Feb 16There Are Some Reasons To Suggest That Suzuken's (TSE:9987) Earnings Are A Poor Reflection Of Profitability
Nov 21Analysts Are Updating Their Suzuken Co., Ltd. (TSE:9987) Estimates After Its Interim Results
Nov 17Do Suzuken's (TSE:9987) Earnings Warrant Your Attention?
Oct 28Calculating The Intrinsic Value Of Suzuken Co., Ltd. (TSE:9987)
Sep 05Subdued Growth No Barrier To Suzuken Co., Ltd.'s (TSE:9987) Price
Jul 11Here's Why We Think Suzuken (TSE:9987) Is Well Worth Watching
Jun 12Shareholders Can Be Confident That Suzuken's (TSE:9987) Earnings Are High Quality
May 22Investor Optimism Abounds Suzuken Co., Ltd. (TSE:9987) But Growth Is Lacking
Mar 22Shareholder Returns
| 9987 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | -2.2% | 2.9% | 2.8% |
| 1Y | 12.8% | 7.9% | 23.0% |
Return vs Industry: 9987 exceeded the JP Healthcare industry which returned 7.9% over the past year.
Return vs Market: 9987 underperformed the JP Market which returned 23% over the past year.
Price Volatility
| 9987 volatility | |
|---|---|
| 9987 Average Weekly Movement | 3.3% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in JP Market | 7.9% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 9987 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 9987's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 12,923 | Shigeru Asano | www.suzuken.co.jp |
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplies medical institutions, and insurance pharmacies.
Suzuken Co., Ltd. Fundamentals Summary
| 9987 fundamental statistics | |
|---|---|
| Market cap | JP¥416.17b |
| Earnings (TTM) | JP¥33.32b |
| Revenue (TTM) | JP¥2.41t |
Is 9987 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9987 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.41t |
| Cost of Revenue | JP¥2.22t |
| Gross Profit | JP¥192.18b |
| Other Expenses | JP¥158.87b |
| Earnings | JP¥33.32b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 476.80 |
| Gross Margin | 7.97% |
| Net Profit Margin | 1.38% |
| Debt/Equity Ratio | 0% |
How did 9987 perform over the long term?
See historical performance and comparisonDividends
Does 9987 pay a reliable dividends?
See 9987 dividend history and benchmarks| Suzuken dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2025 |
| Dividend Pay Date | Dec 10 2025 |
| Days until Ex dividend | 46 days |
| Days until Dividend pay date | 26 days |
Does 9987 pay a reliable dividends?
See 9987 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/13 14:30 |
| End of Day Share Price | 2025/11/13 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Suzuken Co., Ltd. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Ritsuo Watanabe | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |